染色体调节器突变的瘤与更高的突变负担和改善对检查点免疫疗法的反应有关
Marija Gjorgjievska1, Djansel Bukovec1, Sanja Mehandziska1
1Zan Mitrev Clinic, Skopje, Republic of Macedonia.
Clinical epigenetics
|December 31, 2025
概括
染色体调节器 (CRs) 的突变与较高的瘤突变负担 (TMB) 和癌症患者对免疫检查点抑制剂 (ICI) 治疗的反应改善有关.
科学领域:
- 癌症基因组学 癌症基因组学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 染色体调节器 (CRs) 的遗传缺陷在癌症发生过程中很常见.
- 瘤突变负担 (TMB) 是对免疫检查点抑制剂 (ICI) 治疗反应的潜在预测因素.
研究的目的:
- 分析CR突变在癌症中的分布和特征.
- 调查CR突变,TMB和ICI治疗反应之间的关系.
主要方法:
- 在成千上万的瘤样本中分析CR基因突变.
- CR突变与瘤突变负担 (TMB) 的相关性.
- 在CR突变患者中评估ICI治疗反应.
主要成果:
- 具有CR突变的瘤表现出明显更高的TMB.
- 同时发生的CR突变进一步增加了TMB.
- 患有CR突变的患者对ICI治疗的反应有所改善,类似于DNA修复缺陷患者.
结论:
- 染色体调节者的突变与关键癌症特征有显著的关联,包括高TMB.
- CR突变预测了对免疫检查点抑制剂治疗的增强反应.
- 需要进一步研究CR突变在癌症中的功能和临床影响.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K


